New Results
Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts
View ORCID ProfileAdam C. Palmer, View ORCID ProfileDeborah Plana, Hui Gao, Joshua M Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E McLaughlin, David A Ruddy, Colleen Kowal, Julie Goldovitz, Caroline Bullock, Stacy Rivera, Daniel Rakiec, GiNell Elliott, Paul Fordjour, Ronald Meyer, Alice Loo, Esther Kurth, Jeffrey A Engelman, Hans Bitter, William R Sellers, View ORCID ProfilePeter K Sorger, Juliet A Williams
doi: https://doi.org/10.1101/2020.01.08.898734
Adam C. Palmer
1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
2Department of Pharmacology, Computational Medicine Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Deborah Plana
1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
3Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA
4Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School and MIT, Cambridge, Massachusetts, USA
Hui Gao
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Joshua M Korn
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Guizhi Yang
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
John Green
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Xiamei Zhang
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Roberto Velazquez
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Margaret E McLaughlin
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
David A Ruddy
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Colleen Kowal
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Julie Goldovitz
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Caroline Bullock
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Stacy Rivera
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Daniel Rakiec
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
GiNell Elliott
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Paul Fordjour
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Ronald Meyer
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Alice Loo
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Esther Kurth
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Jeffrey A Engelman
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Hans Bitter
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
William R Sellers
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Peter K Sorger
1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
3Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA
Juliet A Williams
5Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Posted January 13, 2020.
Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts
Adam C. Palmer, Deborah Plana, Hui Gao, Joshua M Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E McLaughlin, David A Ruddy, Colleen Kowal, Julie Goldovitz, Caroline Bullock, Stacy Rivera, Daniel Rakiec, GiNell Elliott, Paul Fordjour, Ronald Meyer, Alice Loo, Esther Kurth, Jeffrey A Engelman, Hans Bitter, William R Sellers, Peter K Sorger, Juliet A Williams
bioRxiv 2020.01.08.898734; doi: https://doi.org/10.1101/2020.01.08.898734
Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts
Adam C. Palmer, Deborah Plana, Hui Gao, Joshua M Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E McLaughlin, David A Ruddy, Colleen Kowal, Julie Goldovitz, Caroline Bullock, Stacy Rivera, Daniel Rakiec, GiNell Elliott, Paul Fordjour, Ronald Meyer, Alice Loo, Esther Kurth, Jeffrey A Engelman, Hans Bitter, William R Sellers, Peter K Sorger, Juliet A Williams
bioRxiv 2020.01.08.898734; doi: https://doi.org/10.1101/2020.01.08.898734
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)